1. INTRODUCTION

1.1. RESEARCH OBJECTIVES

1.2. RESEARCH METHODOLOGY

1.3. RESEARCH PROCESS

1.4. SCOPE AND COVERAGE

1.4.1. Market Definition

1.4.2. Key Questions Answered

1.5. MARKET SEGMENTATION

2. EXECUTIVE SUMMARY

3. MARKET OVERVIEW

4. GROWTH OPPORTUNITIES BY SEGMENT

5. MARKET LANDSCAPE

5.1. PORTER’S FIVE FORCES ANALYSIS

5.1.1. Bargaining Power Of Supplier

5.1.2. Threat Of New Entrants

5.1.3. Threat Of Substitutes

5.1.4. Competitive Rivalry

5.1.5. Bargaining Power Among Buyers

5.2. INDUSTRY VALUE CHAIN ANALYSIS

5.3. MARKET DYNAMICS

5.3.1. Drivers

5.3.2. Restraints

5.3.3. Opportunities

5.3.4. Challenges

5.4. MARKET TREND ANALYSIS

5.5. REGULATORY LANDSCAPE

5.6. PESTLE ANALYSIS

5.7. PRICE TREND ANALYSIS

5.8. PATENT ANALYSIS

5.9. DISEASE INDICATION EVALUATION

5.10. MARKET IMPACT OF THE RUSSIA-UKRAINE WAR

5.10.1. Geopolitical Market Disruptions

5.10.2. Supply Chain Disruptions

5.10.3. Instability in Emerging Markets

5.11. ECOSYSTEM

6. ORAL THIN FILM DRUGS MARKET BY PRODUCT (2023-2033)

6.1. ORAL THIN FILM DRUGS MARKET SNAPSHOT AND GROWTH ENGINE

6.2. MARKET OVERVIEW

6.3. FAST DISSOLVING BUCCAL FILM

6.3.1. Introduction And Market Overview

6.3.2. Historic And Forecasted Market Size in Value (2023-2033F)

6.3.3. Historic And Forecasted Market Size in Volume (2023-2033F)

6.3.4. Key Market Trends, Growth Factors and Opportunities

6.3.5. Geographic Segmentation Analysis

6.4. SUBLINGUAL

7. ORAL THIN FILM DRUGS MARKET BY DISEASE INDICATION (2023-2033)

7.1. ORAL THIN FILM DRUGS MARKET SNAPSHOT AND GROWTH ENGINE

7.2. MARKET OVERVIEW

7.3. OPIOID DEPENDENCE

7.3.1. Introduction And Market Overview

7.3.2. Historic And Forecasted Market Size in Value (2023-2033F)

7.3.3. Historic And Forecasted Market Size in Volume (2023-2033F)

7.3.4. Key Market Trends, Growth Factors And Opportunities

7.3.5. Geographic Segmentation Analysis

7.4. NAUSEA & VOMITING

7.5. SCHIZOPHRENIA

7.6. MIGRAINE

8. ORAL THIN FILM DRUGS MARKET BY DISTRIBUTION CHANNEL (2023-2033)

8.1. ORAL THIN FILM DRUGS MARKET SNAPSHOT AND GROWTH ENGINE

8.2. MARKET OVERVIEW

8.3. RETAIL PHARMACIES

8.3.1. Introduction And Market Overview

8.3.2. Historic And Forecasted Market Size in Value (2023-2033F)

8.3.3. Historic And Forecasted Market Size in Volume (2023-2033F)

8.3.4. Key Market Trends, Growth Factors And Opportunities

8.3.5. Geographic Segmentation Analysis

8.4. HOSPITAL PHARMACIES

8.5. ONLINE DRUG STORES

9. COMPANY PROFILES AND COMPETITIVE ANALYSIS

9.1. COMPETITIVE LANDSCAPE

9.1.1. Competitive Benchmarking

9.1.2. ORAL THIN FILM DRUGS MARKET Share By Manufacturer (2023)

9.1.3. Industry BCG Matrix

9.1.4. Heat Map Analysis

9.1.5. Mergers & Acquisitions

9.2. JOHNSON & JOHNSON SERVICES

9.2.1. Company Overview

9.2.2. Key Executives

9.2.3. Company Snapshot

9.2.4. Role of the Company in the Market

9.2.5. Sustainability and Social Responsibility

9.2.6. Operating Business Segments

9.2.7. Product Portfolio

9.2.8. Business Performance (Production Volume, Sales Volume, Sales Margin, Production Capacity, Capacity Utilization Rate)

9.2.9. Key Strategic Moves And Recent Developments

9.2.10. SWOT Analysis

9.3. CURE Pharmaceutical

9.4. PFIZER INC

9.5. LTS LOHMANN THERAPIE-SYSTEME AG

9.6. NOVARTIS AG

9.7. INDIVIOR PLC

9.8. GLAXOSMITHKLINE PLC

9.9. TESA LABTEC GMBH

9.10. ALLERGAN PLC.

9.11. SUMITOMO DAINIPPON PHARMA CO.

9.12. OTHER KEY PLAYERS

10. GLOBAL ORAL THIN FILM DRUGS MARKET BY REGION

10.1. OVERVIEW

10.2. NORTH AMERICA

10.2.1. Key Market Trends, Growth Factors And Opportunities

10.2.2. Key Manufacturers

10.2.3. Historic And Forecasted Market Size By PRODUCT

10.2.4. Historic And Forecasted Market Size By DISEASE INDICATION

10.2.5. Historic And Forecasted Market Size By DISTRIBUTION CHANNEL

10.2.6. Historic And Forecasted Market Size By Country

10.2.6.1. USA

10.2.6.2. Canada

10.2.6.3. Mexico

10.3. EASTERN EUROPE

10.3.1. Key Market Trends, Growth Factors And Opportunities

10.3.2. Key Manufacturers

10.3.3. Historic And Forecasted Market Size By Segments

10.3.4. Historic And Forecasted Market Size By Country

10.3.4.1. Russia

10.3.4.2. Bulgaria

10.3.4.3. The Czech Republic

10.3.4.4. Hungary

10.3.4.5. Poland

10.3.4.6. Romania

10.3.4.7. Rest Of Eastern Europe

10.4. WESTERN EUROPE

10.4.1. Key Market Trends, Growth Factors And Opportunities

10.4.2. Key Manufacturers

10.4.3. Historic And Forecasted Market Size By Segments

10.4.4. Historic And Forecasted Market Size By Country

10.4.4.1. Germany

10.4.4.2. United Kingdom

10.4.4.3. France

10.4.4.4. The Netherlands

10.4.4.5. Italy

10.4.4.6. Spain

10.4.4.7. Rest Of Western Europe

10.5. ASIA PACIFIC

10.5.1. Key Market Trends, Growth Factors And Opportunities

10.5.2. Key Manufacturers

10.5.3. Historic And Forecasted Market Size By Segments

10.5.4. Historic And Forecasted Market Size By Country

10.5.4.1. China

10.5.4.2. India

10.5.4.3. Japan

10.5.4.4. South Korea

10.5.4.5. Malaysia

10.5.4.6. Thailand

10.5.4.7. Vietnam

10.5.4.8. The Philippines

10.5.4.9. Australia

10.5.4.10. New-Zealand

10.5.4.11. Rest Of APAC

10.6. MIDDLE EAST & AFRICA

10.6.1. Key Market Trends, Growth Factors And Opportunities

10.6.2. Key Manufacturers

10.6.3. Historic And Forecasted Market Size By Segments

10.6.4. Historic And Forecasted Market Size By Country

10.6.4.1. Turkey

10.6.4.2. Bahrain

10.6.4.3. Kuwait

10.6.4.4. Saudi Arabia

10.6.4.5. Qatar

10.6.4.6. UAE

10.6.4.7. Israel

10.6.4.8. South Africa

10.7. SOUTH AMERICA

10.7.1. Key Market Trends, Growth Factors And Opportunities

10.7.2. Key Manufacturers

10.7.3. Historic And Forecasted Market Size By Segments

10.7.4. Historic And Forecasted Market Size By Country

10.7.4.1. Brazil

10.7.4.2. Argentina

10.7.4.3. Rest of South America

11. INVESTMENT ANALYSIS

12. ANALYST VIEWPOINT AND CONCLUSION

12.1. Recommendations and Concluding Analysis

12.2. Potential Market Strategies

Report	Oral Thin Film Drugs Market
Selected License	Single ID:IMR1097

Buyer Information

Order Summary